Abstract
Serotonin syndrome is a potentially life-threatening syndrome associated with drug-induced changes in serotonin receptor sensitivities in the central nervous system. Mental status changes, neuromuscular hyperactivity, and autonomic dysfunction characterize the syndrome and can range from benign to lethal. Serotonin syndrome typically results from therapeutic use of two or more serotonergic drugs. However, commonly prescribed serotonergic drugs may interact with medications and drugs used in anesthetic and critical care practice to precipitate serotonin syndrome. It is important to identify the patient at risk, as well as the clinical features of serotonin syndrome should they develop. Prompt recognition of the signs and symptoms of serotonin syndrome is essential for efficient diagnosis and treatment of this rare, yet preventable condition.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005;352:1112–20.
Morgan GE, Mikhail MS, Murray MJ. Lange – clinical anesthesiology. 4th ed. New York: McGraw-Hill; 2006.
Volpi-Abadie J, Kaye AM, Kaye AD. Serotonin syndrome. Ochsner J. 2013;13(4):533–40.
Koichi N, Yoshino T, Yui K, Katoh S. Potent serotonin (5-HT) 2A receptor antagonists completely prevent the development of hyperthermia in an animal model of the 5-HT syndrome. Brain Res. 2001;890:23–31.
Dvir Y, Smallwood P. Serotonin syndrome: a complex but easily avoidable condition. Gen Hosp Psychiatry. 2008;30:284–7.
Nisijima K, Shioda K, Yoshino T, Takano K, Kate S. Diazepam and chlormethiazole attenuate the development of hyperthermia in an animal model of serotonin syndrome. Neurochem Int. 2003;43:155–64.
Mitchell PB. Drug interaction of clinical significance with selective serotonin reuptake inhibitors. Drug Saf. 1997;17:390–406.
Lange-Asschenfeldt C, Weigmann H, Hiemke C, Mann K. Serotonin syndrome as a result of fluoxetine in a patient with tramadol abuse: plasma level-correlated symptomatology. J Clin Psychopharmacol. 2002;22:440–1.
Mason BJ, Blackburn KH. Possible serotonin syndrome associated with tramadol and sertraline coadministration. Ann Pharmacother. 1997;31:175–7.
Ables AZ, Nagubilli R. Prevention, diagnosis, and management of serotonin syndrome. Am Fam Physician. 2010;81(9):1139–42.
Lee J, Franz L, Goforth HW. Serotonin syndrome in a chronic-pain patient receiving concurrent methadone, ciprofloxacin and venlafaxine. Psychosomatics. 2009;50:638–9.
Levin TT, Cortes-Ladino A, Weiss M, Palomba ML. Life-threatening serotonin toxicity due to a citalopram-fluconazole drug interaction: case reports and discussion. Gen Hosp Psychiatry. 2008;30:372–7.
Walsh J. Serotonin syndrome. Anaesthesia tutorial of the week 166. 18 Jan 2010 from www.totw.anaesthesiologists.org.
Peck T, Wong A, Norman E. Anaesthetic implications of psychoactive drugs. Contin Educ Anaesth Crit Care Pain. 2010;10(6):177–81.
Boyer EW, Traub SJ, Grayzel J. Serotonin syndrome. UpToDate. 2010. Retrieved 28 Sep 2011, from UpToDate.com.
Chinniah S, French JLH, Levy DM. Serotonin and anaesthesia. Contin Educ Anaesth Crit Care Pain. 2008;8(2):43–5.
Guo SL, Wu TJ, Liu CC, Ng CC, Chien CC, Sun HL. Meperidine-induced serotonin syndrome in a susceptible patient. Br J Anaesth. 2009;103(3):369–70.
Dunkley EJC, Isbister GK, Sibbritt D, Dawson AH, Whyte IM. The hunter serotonin toxicity criteria: simple and accurate diagnostic decision rules for serotonin toxicity. QJM. 2003;96:635–62.
Graudins A, Stearman A, Chan B. Treatment of serotonin syndrome with cyproheptadine. J Emerg Med. 1998;16:615–9.
McDaniel WW. Serotonin syndrome: early management with cyproheptadine. Ann Pharmacother. 2001;35:870–3.
Gillman PK. Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity. Br J Anaesth. 2005;95(4):434–41.
Isbister GK, Bowe SJ, Dawson A, Whyte IM. Relative toxicity of selective serotonin reuptake inhibitors (SSRIs) in overdose. J Toxicol Clin Toxicol. 2004;42:277–85.
Altman CS, Jahangiri MF. Serotonin syndrome in the perioperative period. Anesth Analg. 2010;110(2):526–8.
Jones D, Story DA. Serotonin syndrome and the anaesthetist. Anaesth Intensive Care. 2005;33:181–7.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this chapter
Cite this chapter
Gayle, J.A., Abadie, J.V., Kaye, A.M., Kaye, A.D. (2015). Serotonin Syndrome. In: Kaye, A., Kaye, A., Urman, R. (eds) Essentials of Pharmacology for Anesthesia, Pain Medicine, and Critical Care. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-8948-1_49
Download citation
DOI: https://doi.org/10.1007/978-1-4614-8948-1_49
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-8947-4
Online ISBN: 978-1-4614-8948-1
eBook Packages: MedicineMedicine (R0)